248 related articles for article (PubMed ID: 21550790)
1. Use of respondent-driven sampling to enhance understanding of injecting networks: a study of people who inject drugs in Sydney, Australia.
Paquette DM; Bryant J; De Wit J
Int J Drug Policy; 2011 Jul; 22(4):267-73. PubMed ID: 21550790
[TBL] [Abstract][Full Text] [Related]
2. Respondent-driven sampling and the recruitment of people with small injecting networks.
Paquette D; Bryant J; de Wit J
AIDS Behav; 2012 May; 16(4):890-9. PubMed ID: 21874352
[TBL] [Abstract][Full Text] [Related]
3. Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting.
Bryant J; Brener L; Hull P; Treloar C
Drug Alcohol Depend; 2010 Mar; 107(2-3):182-7. PubMed ID: 19942380
[TBL] [Abstract][Full Text] [Related]
4. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
[TBL] [Abstract][Full Text] [Related]
5. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
[TBL] [Abstract][Full Text] [Related]
6. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
7. Conducting a respondent-driven sampling survey with the use of existing resources in Sydney, Australia.
Paquette DM; Bryant J; Crawford S; de Wit JB
Drug Alcohol Depend; 2011 Jul; 116(1-3):125-31. PubMed ID: 21257275
[TBL] [Abstract][Full Text] [Related]
8. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.
Iversen J; Wand H; Gonnermann A; Maher L;
Int J Drug Policy; 2010 Nov; 21(6):471-6. PubMed ID: 20472417
[TBL] [Abstract][Full Text] [Related]
10. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C viral infection and imprisonment among Aboriginal and Torres Strait Islander and non-Indigenous people who inject drugs.
Smirnov A; Kemp R; Ward J; Henderson S; Williams S; Dev A; Najman JM
Drug Alcohol Rev; 2018 Nov; 37(7):831-836. PubMed ID: 30009499
[TBL] [Abstract][Full Text] [Related]
12. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
Larance B; Degenhardt L; Copeland J; Dillon P
Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
[TBL] [Abstract][Full Text] [Related]
13. Staying safe from hepatitis C: engaging with multiple priorities.
Harris M; Treloar C; Maher L
Qual Health Res; 2012 Jan; 22(1):31-42. PubMed ID: 21873284
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
[TBL] [Abstract][Full Text] [Related]
15. The importance of social networks in their association to drug equipment sharing among injection drug users: a review.
De P; Cox J; Boivin JF; Platt RW; Jolly AM
Addiction; 2007 Nov; 102(11):1730-9. PubMed ID: 17935581
[TBL] [Abstract][Full Text] [Related]
16. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
[TBL] [Abstract][Full Text] [Related]
17. Risk practices among aboriginal people who inject drugs in New South Wales, Australia.
Paquette D; McEwan M; Bryant J
AIDS Behav; 2013 Sep; 17(7):2467-73. PubMed ID: 22711223
[TBL] [Abstract][Full Text] [Related]
18. "We get by with a little help from our friends": Small-scale informal and large-scale formal peer distribution networks of sterile injecting equipment in Australia.
Newland J; Newman C; Treloar C
Int J Drug Policy; 2016 Aug; 34():65-71. PubMed ID: 27449331
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C prevalence and risk behavior of injecting drug users in Sydney: a continuing concern.
Habib SE; Lovejoy FH; Aspin C
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):823-34. PubMed ID: 12041560
[TBL] [Abstract][Full Text] [Related]
20. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment.
Gossop M; Griffiths P; Powis B; Strang J
AIDS Care; 1993; 5(2):159-68. PubMed ID: 8392383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
